Shopping Cart 0
Cart Subtotal
AED 0

Global Subcutaneous Immunoglobulins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 25543

Details

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Scope of the Report:

This report focuses on the Subcutaneous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.

Market competition is intense. In United States, only Shire (Baxalta), Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Subcutaneous Immunoglobulins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Shire (Baxalta)

Grifols

CSL

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

10% Purity

20% Purity

Market Segment by Applications, can be divided into

Primary Immunodeficiency

Secondary Immunodeficiency

Others

There are 15 Chapters to deeply display the global Subcutaneous Immunoglobulins market.

Chapter 1, to describe Subcutaneous Immunoglobulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Subcutaneous Immunoglobulins, with sales, revenue, and price of Subcutaneous Immunoglobulins, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Subcutaneous Immunoglobulins, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Subcutaneous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Subcutaneous Immunoglobulins Introduction

1.2 Market Analysis by Type

1.2.1 10% Purity

1.2.2 20% Purity

1.3 Market Analysis by Applications

1.3.1 Primary Immunodeficiency

1.3.2 Secondary Immunodeficiency

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Shire (Baxalta)

2.1.1 Business Overview

2.1.2 Subcutaneous Immunoglobulins Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Grifols

2.2.1 Business Overview

2.2.2 Subcutaneous Immunoglobulins Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 CSL

2.3.1 Business Overview

2.3.2 Subcutaneous Immunoglobulins Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Subcutaneous Immunoglobulins Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017

3.3.2 Top 6 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Subcutaneous Immunoglobulins Market Analysis by Regions

4.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Regions

4.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Regions (2013-2018)

4.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Regions (2013-2018)

4.2 North America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.3 Europe Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.5 South America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

5 North America Subcutaneous Immunoglobulins by Countries

5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

5.1.1 North America Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

5.1.2 North America Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

5.2 United States Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

5.3 Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

5.4 Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6 Europe Subcutaneous Immunoglobulins by Countries

6.1 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

6.1.1 Europe Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

6.2 Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.3 UK Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.4 France Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.5 Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.6 Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7 Asia-Pacific Subcutaneous Immunoglobulins by Countries

7.1 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

7.2 China Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.3 Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.4 Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.5 India Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

8 South America Subcutaneous Immunoglobulins by Countries

8.1 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

8.1.1 South America Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

8.1.2 South America Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

8.3 Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

8.4 Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9 Middle East and Africa Subcutaneous Immunoglobulins by Countries

9.1 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.3 UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.4 Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.5 Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.6 South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

10 Global Subcutaneous Immunoglobulins Market Segment by Type

10.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Type (2013-2018)

10.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2013-2018)

10.2 10% Purity Sales Growth and Price

10.2.1 Global 10% Purity Sales Growth (2013-2018)

10.2.2 Global 10% Purity Price (2013-2018)

10.3 20% Purity Sales Growth and Price

10.3.1 Global 20% Purity Sales Growth (2013-2018)

10.3.2 Global 20% Purity Price (2013-2018)

11 Global Subcutaneous Immunoglobulins Market Segment by Application

11.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2013-2018)

11.2 Primary Immunodeficiency Sales Growth (2013-2018)

11.3 Secondary Immunodeficiency Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)

12.2 Subcutaneous Immunoglobulins Market Forecast by Regions (2018-2023)

12.2.1 North America Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.2 Europe Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.4 South America Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.3 Subcutaneous Immunoglobulins Market Forecast by Type (2018-2023)

12.3.1 Global Subcutaneous Immunoglobulins Sales Forecast by Type (2018-2023)

12.3.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2018-2023)

12.4 Subcutaneous Immunoglobulins Market Forecast by Application (2018-2023)

12.4.1 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2018-2023)

12.4.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Subcutaneous Immunoglobulins Picture

Table Product Specifications of Subcutaneous Immunoglobulins

Figure Global Sales Market Share of Subcutaneous Immunoglobulins by Types in 2017

Table Subcutaneous Immunoglobulins Types for Major Manufacturers

Figure 10% Purity Picture

Figure 20% Purity Picture

Figure Subcutaneous Immunoglobulins Sales Market Share by Applications in 2017

Figure Primary Immunodeficiency Picture

Figure Secondary Immunodeficiency Picture

Figure Others Picture

Figure United States Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure France Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure UK Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure China Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure India Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors

Table Shire (Baxalta) Subcutaneous Immunoglobulins Type and Applications

Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Grifols Basic Information, Manufacturing Base and Competitors

Table Grifols Subcutaneous Immunoglobulins Type and Applications

Table Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table CSL Basic Information, Manufacturing Base and Competitors

Table CSL Subcutaneous Immunoglobulins Type and Applications

Table CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)

Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016

Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017

Table Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017

Figure Top 3 Subcutaneous Immunoglobulins Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Subcutaneous Immunoglobulins Manufacturer (Revenue) Market Share in 2017

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Global Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales by Regions (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales Market Share by Regions (2013-2018)

Table Global Subcutaneous Immunoglobulins Revenue by Regions (2013-2018)

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2013

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2017

Figure North America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Europe Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure South America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure North America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table North America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table North America Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2013

Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017

Table North America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Table North America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)

Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2013

Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure United States Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Europe Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Europe Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Table Europe Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016

Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure UK Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure France Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries 2017

Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Countries 2017

Figure China Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure India Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure South America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table South America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table South America Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure South America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017

Table South America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Table South America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)

Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017

Table Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Table Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2013

Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales by Type (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales Share by Type (2013-2018)

Table Global Subcutaneous Immunoglobulins Revenue by Type (2013-2018)

Table Global Subcutaneous Immunoglobulins Revenue Share by Type (2013-2018)

Figure Global 10% Purity Sales Growth (2013-2018)

Figure Global 10% Purity Price (2013-2018)

Figure Global 20% Purity Sales Growth (2013-2018)

Figure Global 20% Purity Price (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales by Application (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales Share by Application (2013-2018)

Figure Global Secondary Immunodeficiency Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)

Table Global Subcutaneous Immunoglobulins Sales Forecast by Regions (2018-2023)

Table Global Subcutaneous Immunoglobulins Market Share Forecast by Regions (2018-2023)

Figure North America Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure Europe Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure Asia-Pacific Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure South America Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure Middle East and Africa Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Table Global Subcutaneous Immunoglobulins Sales Forecast by Type (2018-2023)

Table Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2018-2023)

Table Global Subcutaneous Immunoglobulins Sales Forecast by Application (2018-2023)

Table Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Shire (Baxalta)

Grifols

CSL

Company Profile

Company Profile Title

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Scope of the Report:

This report focuses on the Subcutaneous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.

Market competition is intense. In United States, only Shire (Baxalta), Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Subcutaneous Immunoglobulins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Shire (Baxalta)

Grifols

CSL

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

10% Purity

20% Purity

Market Segment by Applications, can be divided into

Primary Immunodeficiency

Secondary Immunodeficiency

Others

There are 15 Chapters to deeply display the global Subcutaneous Immunoglobulins market.

Chapter 1, to describe Subcutaneous Immunoglobulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Subcutaneous Immunoglobulins, with sales, revenue, and price of Subcutaneous Immunoglobulins, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Subcutaneous Immunoglobulins, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Subcutaneous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Subcutaneous Immunoglobulins Introduction

1.2 Market Analysis by Type

1.2.1 10% Purity

1.2.2 20% Purity

1.3 Market Analysis by Applications

1.3.1 Primary Immunodeficiency

1.3.2 Secondary Immunodeficiency

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Shire (Baxalta)

2.1.1 Business Overview

2.1.2 Subcutaneous Immunoglobulins Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Grifols

2.2.1 Business Overview

2.2.2 Subcutaneous Immunoglobulins Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 CSL

2.3.1 Business Overview

2.3.2 Subcutaneous Immunoglobulins Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Subcutaneous Immunoglobulins Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017

3.3.2 Top 6 Subcutaneous Immunoglobulins Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Subcutaneous Immunoglobulins Market Analysis by Regions

4.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Regions

4.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Regions (2013-2018)

4.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Regions (2013-2018)

4.2 North America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.3 Europe Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.5 South America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

5 North America Subcutaneous Immunoglobulins by Countries

5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

5.1.1 North America Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

5.1.2 North America Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

5.2 United States Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

5.3 Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

5.4 Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6 Europe Subcutaneous Immunoglobulins by Countries

6.1 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

6.1.1 Europe Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

6.2 Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.3 UK Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.4 France Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.5 Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

6.6 Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7 Asia-Pacific Subcutaneous Immunoglobulins by Countries

7.1 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

7.2 China Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.3 Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.4 Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.5 India Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

8 South America Subcutaneous Immunoglobulins by Countries

8.1 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

8.1.1 South America Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

8.1.2 South America Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

8.3 Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

8.4 Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9 Middle East and Africa Subcutaneous Immunoglobulins by Countries

9.1 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.3 UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.4 Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.5 Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

9.6 South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

10 Global Subcutaneous Immunoglobulins Market Segment by Type

10.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Type (2013-2018)

10.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2013-2018)

10.2 10% Purity Sales Growth and Price

10.2.1 Global 10% Purity Sales Growth (2013-2018)

10.2.2 Global 10% Purity Price (2013-2018)

10.3 20% Purity Sales Growth and Price

10.3.1 Global 20% Purity Sales Growth (2013-2018)

10.3.2 Global 20% Purity Price (2013-2018)

11 Global Subcutaneous Immunoglobulins Market Segment by Application

11.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2013-2018)

11.2 Primary Immunodeficiency Sales Growth (2013-2018)

11.3 Secondary Immunodeficiency Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)

12.2 Subcutaneous Immunoglobulins Market Forecast by Regions (2018-2023)

12.2.1 North America Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.2 Europe Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.4 South America Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.2.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast (2018-2023)

12.3 Subcutaneous Immunoglobulins Market Forecast by Type (2018-2023)

12.3.1 Global Subcutaneous Immunoglobulins Sales Forecast by Type (2018-2023)

12.3.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2018-2023)

12.4 Subcutaneous Immunoglobulins Market Forecast by Application (2018-2023)

12.4.1 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2018-2023)

12.4.2 Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Subcutaneous Immunoglobulins Picture

Table Product Specifications of Subcutaneous Immunoglobulins

Figure Global Sales Market Share of Subcutaneous Immunoglobulins by Types in 2017

Table Subcutaneous Immunoglobulins Types for Major Manufacturers

Figure 10% Purity Picture

Figure 20% Purity Picture

Figure Subcutaneous Immunoglobulins Sales Market Share by Applications in 2017

Figure Primary Immunodeficiency Picture

Figure Secondary Immunodeficiency Picture

Figure Others Picture

Figure United States Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure France Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure UK Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure China Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure India Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2013-2023)

Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors

Table Shire (Baxalta) Subcutaneous Immunoglobulins Type and Applications

Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Grifols Basic Information, Manufacturing Base and Competitors

Table Grifols Subcutaneous Immunoglobulins Type and Applications

Table Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table CSL Basic Information, Manufacturing Base and Competitors

Table CSL Subcutaneous Immunoglobulins Type and Applications

Table CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)

Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016

Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017

Table Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017

Figure Top 3 Subcutaneous Immunoglobulins Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Subcutaneous Immunoglobulins Manufacturer (Revenue) Market Share in 2017

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Global Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales by Regions (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales Market Share by Regions (2013-2018)

Table Global Subcutaneous Immunoglobulins Revenue by Regions (2013-2018)

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2013

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2017

Figure North America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Europe Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure South America Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure North America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table North America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table North America Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2013

Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017

Table North America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Table North America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)

Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2013

Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure United States Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Canada Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Mexico Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Europe Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Europe Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Table Europe Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016

Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure UK Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure France Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries 2017

Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Countries 2017

Figure China Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Japan Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Korea Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure India Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Southeast Asia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure South America Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table South America Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table South America Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure South America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017

Table South America Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Table South America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)

Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure Brazil Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Argentina Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Colombia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2013-2018)

Table Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries in 2017

Table Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2013-2018)

Table Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2013

Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2017

Figure Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Figure South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales by Type (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales Share by Type (2013-2018)

Table Global Subcutaneous Immunoglobulins Revenue by Type (2013-2018)

Table Global Subcutaneous Immunoglobulins Revenue Share by Type (2013-2018)

Figure Global 10% Purity Sales Growth (2013-2018)

Figure Global 10% Purity Price (2013-2018)

Figure Global 20% Purity Sales Growth (2013-2018)

Figure Global 20% Purity Price (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales by Application (2013-2018)

Table Global Subcutaneous Immunoglobulins Sales Share by Application (2013-2018)

Figure Global Secondary Immunodeficiency Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2018-2023)

Table Global Subcutaneous Immunoglobulins Sales Forecast by Regions (2018-2023)

Table Global Subcutaneous Immunoglobulins Market Share Forecast by Regions (2018-2023)

Figure North America Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure Europe Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure Asia-Pacific Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure South America Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Figure Middle East and Africa Sales Subcutaneous Immunoglobulins Market Forecast (2018-2023)

Table Global Subcutaneous Immunoglobulins Sales Forecast by Type (2018-2023)

Table Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2018-2023)

Table Global Subcutaneous Immunoglobulins Sales Forecast by Application (2018-2023)

Table Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Shire (Baxalta)

Grifols

CSL